These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 36720919)
1. TRPV1 regulates ApoE4-disrupted intracellular lipid homeostasis and decreases synaptic phagocytosis by microglia. Wang C; Lu J; Sha X; Qiu Y; Chen H; Yu Z Exp Mol Med; 2023 Feb; 55(2):347-363. PubMed ID: 36720919 [TBL] [Abstract][Full Text] [Related]
2. A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson's disease. Lu J; Wang C; Cheng X; Wang R; Yan X; He P; Chen H; Yu Z J Neuroinflammation; 2022 May; 19(1):113. PubMed ID: 35599331 [TBL] [Abstract][Full Text] [Related]
3. TRPV1 sustains microglial metabolic reprogramming in Alzheimer's disease. Lu J; Zhou W; Dou F; Wang C; Yu Z EMBO Rep; 2021 Jun; 22(6):e52013. PubMed ID: 33998138 [TBL] [Abstract][Full Text] [Related]
4. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Wang C; Xiong M; Gratuze M; Bao X; Shi Y; Andhey PS; Manis M; Schroeder C; Yin Z; Madore C; Butovsky O; Artyomov M; Ulrich JD; Holtzman DM Neuron; 2021 May; 109(10):1657-1674.e7. PubMed ID: 33831349 [TBL] [Abstract][Full Text] [Related]
5. Activation of transient receptor potential vanilloid 1 ameliorates tau accumulation-induced synaptic damage and cognitive dysfunction via autophagy enhancement. Zhang T; Tian Y; Zheng X; Li R; Hu L; Shui X; Mei Y; Wang Q; Zhang M; Zheng X; Wang L; Chen D; Tao W; Lee TH CNS Neurosci Ther; 2024 Mar; 30(3):e14432. PubMed ID: 37641913 [TBL] [Abstract][Full Text] [Related]
6. TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer's Disease-Associated Pathology and Cognitive Decline. Wang C; Huang W; Lu J; Chen H; Yu Z Front Pharmacol; 2021; 12():763866. PubMed ID: 35115924 [TBL] [Abstract][Full Text] [Related]
8. Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor δ activation. Li Q; Li L; Wang F; Chen J; Zhao Y; Wang P; Nilius B; Liu D; Zhu Z Pflugers Arch; 2013 Sep; 465(9):1303-16. PubMed ID: 23605066 [TBL] [Abstract][Full Text] [Related]
9. α7 Nicotinic acetylcholine receptor contributes to the alleviation of lung ischemia-reperfusion injury by transient receptor potential vanilloid type 1 stimulation. Li X; Xu Y; Cheng Y; Wang R J Surg Res; 2018 Oct; 230():164-174. PubMed ID: 30100034 [TBL] [Abstract][Full Text] [Related]
10. Association between abnormal lipid metabolism and Alzheimer's disease: New research has revealed significant findings on the APOE4 genotype in microglia. Hu X; Ma YN; Xia Y Biosci Trends; 2024 Jun; 18(2):195-197. PubMed ID: 38631884 [TBL] [Abstract][Full Text] [Related]
11. Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity. Victor MB; Leary N; Luna X; Meharena HS; Scannail AN; Bozzelli PL; Samaan G; Murdock MH; von Maydell D; Effenberger AH; Cerit O; Wen HL; Liu L; Welch G; Bonner M; Tsai LH Cell Stem Cell; 2022 Aug; 29(8):1197-1212.e8. PubMed ID: 35931030 [TBL] [Abstract][Full Text] [Related]
12. Azelastine desensitization of transient receptor potential vanilloid 1: a potential mechanism explaining its therapeutic effect in nonallergic rhinitis. Singh U; Bernstein JA; Haar L; Luther K; Jones WK Am J Rhinol Allergy; 2014; 28(3):215-24. PubMed ID: 24980233 [TBL] [Abstract][Full Text] [Related]
13. Activation of TRPV1 by capsaicin induces functional kinin B(1) receptor in rat spinal cord microglia. Talbot S; Dias JP; Lahjouji K; Bogo MR; Campos MM; Gaudreau P; Couture R J Neuroinflammation; 2012 Jan; 9():16. PubMed ID: 22264228 [TBL] [Abstract][Full Text] [Related]
14. Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination. Wang N; Wang M; Jeevaratnam S; Rosenberg C; Ikezu TC; Shue F; Doss SV; Alnobani A; Martens YA; Wren M; Asmann YW; Zhang B; Bu G; Liu CC Mol Neurodegener; 2022 Nov; 17(1):75. PubMed ID: 36419137 [TBL] [Abstract][Full Text] [Related]
15. TRPV1 activation alleviates cognitive and synaptic plasticity impairments through inhibiting AMPAR endocytosis in APP23/PS45 mouse model of Alzheimer's disease. Du Y; Fu M; Huang Z; Tian X; Li J; Pang Y; Song W; Tian Wang Y; Dong Z Aging Cell; 2020 Mar; 19(3):e13113. PubMed ID: 32061032 [TBL] [Abstract][Full Text] [Related]
16. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease. Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000 [TBL] [Abstract][Full Text] [Related]
18. Transient receptor potential vanilloid subtype 1 mediates microglial cell death in vivo and in vitro via Ca2+-mediated mitochondrial damage and cytochrome c release. Kim SR; Kim SU; Oh U; Jin BK J Immunol; 2006 Oct; 177(7):4322-9. PubMed ID: 16982866 [TBL] [Abstract][Full Text] [Related]
19. Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis. Ma L; Zhong J; Zhao Z; Luo Z; Ma S; Sun J; He H; Zhu T; Liu D; Zhu Z; Tepel M Cardiovasc Res; 2011 Dec; 92(3):504-13. PubMed ID: 21908651 [TBL] [Abstract][Full Text] [Related]
20. TRPV1 activation impedes foam cell formation by inducing autophagy in oxLDL-treated vascular smooth muscle cells. Li BH; Yin YW; Liu Y; Pi Y; Guo L; Cao XJ; Gao CY; Zhang LL; Li JC Cell Death Dis; 2014 Apr; 5(4):e1182. PubMed ID: 24743737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]